Brinzolamide loaded core-shell nanoparticles for enhanced coronial penetration in the treatment of glaucoma

Brinzolamide loaded core-shell nanoparticles for enhanced coronial penetration in the treatment of glaucoma

A neurodegenerative disorder, glaucoma is a leading cause of blindness in the world. The conventional treatment strategies do not allow the significant penetration of the drug in the cornea. Therefore, we prepare a brinzolamide (Brz) loaded core-shell nanoparticles (NPs) to enhance the coronial pene...

Full description

Bibliographic Details
Main Authors:	Jing Song, Ziping Zhang
Format:	Article
Language:	English
Published:	SAGE Publishing 2020-11-01
Series:	Journal of Applied Biomaterials & Functional Materials
Online Access:	https://doi.org/10.1177/2280800020942712

Similar Items

Brinzolamide/Brimonidine Fixed Combination: Simplifying Glaucoma Treatment Regimens
by: Reza Moosavi, et al.
Published: (2018-10-01)

Co-delivery of brinzolamide and miRNA-124 by biodegradable nanoparticles as a strategy for glaucoma therapy
by: Tingting Li, et al.
Published: (2020-01-01)

Coronial Practice, Indigeneity and Suicide
by: Gordon Tait, et al.
Published: (2018-04-01)

A comparative study on the efficacy of brinzolamide/timolol versus brinzolamide/brimonidine fixed drug combinations in primary open-angle glaucoma
by: Sudeepthi Padala, et al.
Published: (2020-07-01)

Combination of brinzolamide and brimonidine for glaucoma and ocular hypertension: critical appraisal and patient focus
by: Nguyen QH
Published: (2014-06-01)

Contested Deaths and Coronial Justice in the Digital Age
by: Rebecca Scott Bray
Published: (2020-11-01)

Safety and Efficacy of Adding Fixed-Combination Brinzolamide/Timolol Maleate to Prostaglandin Therapy for Treatment of Ocular Hypertension or Glaucoma
by: Anton Hommer, et al.
Published: (2015-01-01)

Brinzolamide ophthalmic suspension: a review of its pharmacology and use in the treatment of open angle glaucoma and ocular hypertension
by: Michele Iester
Published: (2008-10-01)

Comparison of the Intraocular Pressure-Lowering Efficacy and Safety of the Brinzolamide/Brimonidine Fixed-Dose Combination versus Concomitant Use of Brinzolamide and Brimonidine for Management of Open-Angle Glaucoma or Ocular Hypertension
by: Wang N, et al.
Published: (2020-01-01)

Short-term effect of topical brinzolamide-timolol fixed combination on ocular surface of glaucoma patients
by: Penpe Gul Firat, et al.
Published: (2012-12-01)

24-hour intraocular pressure in glaucoma patients randomized to receive dorzolamide or brinzolamide in combination with latanoprost
by: Yoshimi Nakamura, et al.
Published: (2009-07-01)

Six-month results from a Phase III randomized trial of fixed-combination brinzolamide 1% + brimonidine 0.2% versus brinzolamide or brimonidine monotherapy in glaucoma or ocular hypertension
by: Whitson JT, et al.
Published: (2013-06-01)

The CORONIS Trial: international study of caesarean section surgical techniques
by: Juszczak Edmund, et al.
Published: (2011-12-01)

Update and optimal use of a brinzolamide-timolol fixed combination in open-angle glaucoma and ocular hypertension
by: Syed MF, et al.
Published: (2011-09-01)

Maximum Medical Therapy: Brinzolamide/Brimonidine And Travoprost/Timolol Fixed-Dose Combinations In Glaucoma And Ocular Hypertension
by: Lerner SF, et al.
Published: (2019-12-01)

Role of fixed-combination brinzolamide 1%/timolol 0.5% in the treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension
by: Henny JM Beckers, et al.
Published: (2009-10-01)

Brinzolamide 1%/timolol versus dorzolamide 2%/timolol in the treatment of open-angle glaucoma or ocular hypertension: prospective randomized patient-preference study
by: Altafini R, et al.
Published: (2015-12-01)

Addition of a fixed combination of brinzolamide 1%/timolol 0.5% to prostaglandin monotherapy in patients with glaucoma or ocular hypertension
by: Lorenz K, et al.
Published: (2011-12-01)

Efficacy and safety of brinzolamide/timolol fixed combination compared with timolol in Japanese patients with open-angle glaucoma or ocular hypertension
by: Yoshikawa K, et al.
Published: (2014-02-01)

Exploring coronial determination of intent for poisoning-related deaths in Australia, 2001–2013
by: Kate Churruca, et al.
Published: (2017-08-01)

The coroner in England and Wales : coronial decision-making and local variation in case outcomes
by: Mclean, Maxwell
Published: (2015)

Safety and efficacy of a fixed versus unfixed brinzolamide/timolol combination in Japanese patients with open-angle glaucoma or ocular hypertension
by: Nagayama M, et al.
Published: (2014-01-01)

Clinical effectiveness of brinzolamide 1%–brimonidine 0.2% fixed combination for primary open-angle glaucoma and ocular hypertension
by: Sharma S, et al.
Published: (2015-11-01)

Preference for a fixed combination of brinzolamide/timolol versus dorzolamide/ timolol among patients with open-angle glaucoma or ocular hypertension
by: Sanseau A, et al.
Published: (2013-02-01)

Efficacy and Safety of Brinzolamide as Add-On to Prostaglandin Analogues or β-Blocker for Glaucoma and Ocular Hypertension: A Systematic Review and Meta-Analysis
by: Yuanzhi Liu, et al.
Published: (2019-06-01)

Efficacy and safety of brinzolamide/timolol fixed combination compared with timolol in Japanese patients with open-angle glaucoma or ocular hypertension [Erratum]
by: Yoshikawa K, et al.
Published: (2014-05-01)

Optical Enhancement Effect of Gold Nanoparticle-modified Core Shells
by: Yu-YaoCheng, et al.
Published: (2010)

Crystal structure of Brinzolamide: a carbonic anhydrase inhibitor
by: Huirong Zheng, et al.
Published: (2016-05-01)

Brinzolamide-timolol suspension: acceptability and side effect profile
by: Doherty MD, et al.
Published: (2011-03-01)

Engineering of core/shell nanoparticles surface plasmon for increasing of light penetration depth in tissue (modeling and analysis)
by: Sona Faalnouri, et al.
Published: (2017-09-01)

Using Coronial Records to Provide Novel In-Depth Insights into Work-Related Fatal Injury
by: Rebbecca Lilley, et al.
Published: (2020-12-01)

An Opportunity to Be Heard: Family Experiences of Coronial Investigations Into Missing People and Views on Best Practice
by: Stephanie Dartnall, et al.
Published: (2019-11-01)

Understanding drug-related mortality in released prisoners: a review of national coronial records
by: Andrews Jessica Y, et al.
Published: (2012-04-01)

Preparation of Polystyrene Nanoparticles with Core-shell Structure
by: Huang, Jing-Ting, et al.
Published: (2018)

A comparative study on efficacy of fixed combination timolol/brinzolamide versus travoprost monotherapy in drug-naïve open-angle glaucoma patients
by: Alok Dixit, et al.
Published: (2020-04-01)

Effects of brinzolamide vs timolol as an adjunctive medication to latanoprost on circadian intraocular pressure control in primary open-angle glaucoma Japanese patients
by: Makoto Ishikawa, et al.
Published: (2009-09-01)

Shell tailoring of core–shell nanoparticles for heterogeneous catalysis
by: Hubert Szabat, et al.
Published: (2021-07-01)

Fe Core–Carbon Shell Nanoparticles as Advanced MRI Contrast Enhancer
by: Rakesh P. Chaudhary, et al.
Published: (2017-10-01)

Sensitivity of a national coronial database for monitoring unnatural deaths among ex-prisoners in Australia
by: Wade Jessica, et al.
Published: (2011-10-01)

Who rescues who? Understanding aquatic rescues in Australia using coronial data and a survey
by: Richard C. Franklin, et al.
Published: (2019-10-01)